Factors and Characteristics of Heart Rate Variability in Runners
Factors and Characteristics of Heart Rate Variability During Long Distance Running
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: sheng wei, professor
- Phone Number: 18571729969
- Email: shengwei@hust.edu.cn
Study Locations
-
-
Hubei
-
Wuhan, Hubei, China
- Recruiting
- Zhou Qin
-
Contact:
- Zhou Qin
- Phone Number: 15248078650
- Email: 1506507293@qq.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
People have below conditions could be included:
- age is 18-60 years.
- have normal ECG .
- agree to participate in the study.
Exclusion Criteria:
People have below conditions will be excluded:
- have known Congenital heart disease and rheumatic heart disease.
- have known Hypertension and cerebrovascular disease.
- have known Myocarditis and other heart diseases.
- have known Coronary artery disease and severe arrhythmia.
- have known Diabetes with high or low blood glucose.
- have a cold within two weeks before the study.
have other diseases considered unsuitable for participants in this study.
-
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Healthy adults with regular exercise
Subjects will be asked to wear a small monitoring equipment before,during and after a long distance running (over 3 km).
|
Complete a long distance running(over 3 km) within the specified time (30 minutes)
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
change of heart rate variability
Time Frame: up to 1 year
|
Subjects will be asked to wear a small monitoring equipment before,during and after a long distance running (over 3 km), and complete the corresponding amount of exercise within a specified time during the test
|
up to 1 year
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: sheng wei, professor, Huazhong University of Science and Technology
Publications and helpful links
General Publications
- Hua W, Zhang LF, Wu YF, Liu XQ, Guo DS, Zhou HL, Gou ZP, Zhao LC, Niu HX, Chen KP, Mai JZ, Chu LN, Zhang S. Incidence of sudden cardiac death in China: analysis of 4 regional populations. J Am Coll Cardiol. 2009 Sep 15;54(12):1110-8. doi: 10.1016/j.jacc.2009.06.016. No abstract available.
- Iskandar EG, Thompson PD. Exercise-related sudden death due to an unusual coronary artery anomaly. Med Sci Sports Exerc. 2004 Feb;36(2):180-2. doi: 10.1249/01.MSS.0000113685.89906.04.
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- 2021-S039
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.